Gene · 3556
Papers2,323
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,323
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation. | Cardiovasc Res | 2024 | 38563353 | PubTator, text mining | PubMed |
| Identification of core gene in chronic rhinosinusitis with nasal polyps and correlations with inflammation-related genes. | Braz J Otorhinolaryngol | 2024 | 38490010 | PubTator, text mining | PubMed |
| Different Gene Expression Patterns of IL-1 Family Members in Parkinson's Disease: Results from Bayesian Regression Model. | Iran J Allergy Asthma Immunol | 2024 | 38485911 | PubTator, text mining | PubMed |
| Immune endotyping and gene expression profile of patients with chronic rhinosinusitis with nasal polyps in the aspirin-exacerbated respiratory disease (AERD) and the non-AERD subgroups. | Allergy Asthma Clin Immunol | 2024 | 38360807 | PubTator, text mining | PubMed |
| Pan-cancer proteogenomics characterization of tumor immunity. | Cell | 2024 | 38359819 | PubTator, text mining | PubMed |
| Inserting "OFF-to-ON" BODIPY Tags into Cytokines: A Fluorogenic Interleukin IL-33 for Real-Time Imaging of Immune Cells. | ACS Cent Sci | 2024 | 38292608 | PubTator, text mining | PubMed |
| Research Advances in Fusion Protein-Based Drugs for Diabetes Treatment. | Diabetes Metab Syndr Obes | 2024 | 38288338 | PubTator, text mining | PubMed |
| The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology. | Mol Brain | 2024 | 38263055 | PubTator, text mining | PubMed |
| ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled Asthma. | Allergy Asthma Immunol Res | 2024 | 38262389 | PubTator, text mining | PubMed |
| Next-Generation Therapeutic Approaches for Uncontrolled Asthma: Insights Into the Heterogeneity of Non-Type 2 Inflammation. | Allergy Asthma Immunol Res | 2024 | 38262386 | PubTator, text mining | PubMed |
| Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment. | Int J Nanomedicine | 2024 | 38260239 | PubTator, text mining | PubMed |
| Pathological and Therapeutical Implications of Pyroptosis in Psoriasis and Hidradenitis Suppurativa: A Narrative Review. | Curr Issues Mol Biol | 2024 | 38248345 | PubTator, text mining | PubMed |
| Microglia as a Possible Alternative Therapeutic for Dementia. | J Alzheimers Dis Rep | 2024 | 38229830 | PubTator, text mining | PubMed |
| The anoikis-related gene signature predicts survival and correlates with immune infiltration in osteosarcoma. | Aging (Albany NY) | 2024 | 38217543 | PubTator, text mining | PubMed |
| Serum levels of interleukin-33 and mesencephalic astrocyte derived neurotrophic factors in patients with major depressive disorder: a cross-sectional comparative design. | BMC Psychiatry | 2024 | 38216957 | PubTator, text mining | PubMed |
| Vaccines: a promising therapy for myelodysplastic syndrome. | J Hematol Oncol | 2024 | 38191498 | PubTator, text mining | PubMed |
| Directional Endothelial Communication by Polarized Extracellular Vesicle Release. | Circ Res | 2024 | 38174557 | PubTator, text mining | PubMed |
| TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells. | Nat Commun | 2024 | 38167704 | PubTator, text mining | PubMed |
| Machine learning-driven identification of the gene-expression signature associated with a persistent multiple organ dysfunction trajectory in critical illness. | EBioMedicine | 2024 | 38142638 | PubTator, text mining | PubMed |
| Spesolimab for the Treatment of Generalized Pustular Psoriasis. | Drugs | 2024 | 38114719 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3556/papers?page=7